The predominant age category was 4554, accounting for 28.1% of the cohort
In the trial, patients that received the highest, once-weekly 15 mg dose of Zepbound lost on average 18 percent of their body weight compared to those that received placebo
Common side effects of GLP1 drugs include gastrointestinal symptoms, and they may increase the risk of pancreatitis, kidney issues and muscle loss in some patients
While more of an investment, NAD+ Therapy offers unique benefits for cellular energy, brain function, and anti-aging that simply can't be achieved through other methods
doi: 10.1038/nrm2335 190 LipkeKKubis-KubiakAPiwowarA
This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer, senior study author Bernard Fuemmeler, PhD, MPH, of Virginia Commonwealth University Massey Comprehensive Cancer Center said in a news release